Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 5 |
2024 | 1 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
otaao b
(67 results)?
Treatment Strategy for Rifampin-Susceptible Tuberculosis.
N Engl J Med. 2023 Mar 9;388(10):873-887. doi: 10.1056/NEJMoa2212537. Epub 2023 Feb 20.
N Engl J Med. 2023.
PMID: 36808186
Clinical Trial.
Prevalence of COVID-19 infection in TB clinics in Kampala, Uganda.
Otaalo B, Cevik M, Mwebesa E, Nabisere-Arinaitwe R, Zawedde-Muyanja S, Nampala J, Nanziri C, Alinaitwe L, Aber F, Bayigga J, Nankinga B, Laker E, Owarwo NC, Sabiiti W, Adakun S, Kirenga B, Turyahabwe S, Sloan DJ, Sekaggya-Wiltshire C.
Otaalo B, et al.
Int J Tuberc Lung Dis. 2023 Jun 1;27(6):481-483. doi: 10.5588/ijtld.23.0010.
Int J Tuberc Lung Dis. 2023.
PMID: 37231596
No abstract available.
Item in Clipboard
No action is without its side effects: Adverse drug reactions and missed doses of antituberculosis therapy, a scoping review.
Dixon EG, Rasool S, Otaalo B, Motee A, Dear JW, Sloan D, Stagg HR.
Dixon EG, et al. Among authors: otaalo b.
Br J Clin Pharmacol. 2024 Jan;90(1):313-320. doi: 10.1111/bcp.15908. Epub 2023 Oct 9.
Br J Clin Pharmacol. 2024.
PMID: 37712491
Free PMC article.
Review.
Item in Clipboard
"It is not easy": Experiences of people living with HIV and tuberculosis on Tuberculosis treatment in Uganda.
Nabisere-Arinaitwe R, Namatende-Sakwa L, Bayiga J, Nampala J, Alinaitwe L, Aber F, Otaalo B, Musaazi J, King R, Kesby M, Sloan DJ, Sekaggya-Wiltshire C.
Nabisere-Arinaitwe R, et al. Among authors: otaalo b.
J Clin Tuberc Other Mycobact Dis. 2023 Jun 21;33:100385. doi: 10.1016/j.jctube.2023.100385. eCollection 2023 Dec.
J Clin Tuberc Other Mycobact Dis. 2023.
PMID: 38116575
Free PMC article.
Item in Clipboard
Decreased Dolutegravir and Efavirenz Concentrations With Preserved Virological Suppression in Patients With Tuberculosis and Human Immunodeficiency Virus Receiving High-Dose Rifampicin.
Sekaggya-Wiltshire C, Nabisere R, Musaazi J, Otaalo B, Aber F, Alinaitwe L, Nampala J, Najjemba L, Buzibye A, Omali D, Gausi K, Kengo A, Lamorde M, Aarnoutse R, Denti P, Dooley KE, Sloan DJ.
Sekaggya-Wiltshire C, et al. Among authors: otaalo b.
Clin Infect Dis. 2023 Feb 8;76(3):e910-e919. doi: 10.1093/cid/ciac585.
Clin Infect Dis. 2023.
PMID: 35861296
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite